Results
20,923 records
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 11 | Mazzara PhilipGeneral Counsel and Secretary |  ALABAstera Labs, Inc.Open-market sale · 10b5-1 plan | SELL | $109K 1,000 sh | Apr 3, 2026 traded Apr 1, 2026 | |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 11 | Mazzara PhilipGeneral Counsel and Secretary | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $109K 1,000 sh | Apr 3, 2026 traded Apr 1, 2026 | |
Raghavan VaidyanathanChief Technology Officer |
 XMTRXometry, Inc.Open-market sale · 10b5-1 plan |
| SELL |
| $65K 1,541 sh |
| Apr 3, 2026 traded Apr 2, 2026 |
| 11 | Mazzara PhilipGeneral Counsel and Secretary | ALABAstera Labs, Inc. Open-market sale · 10b5-1 plan | SELL | $213K 1,985 sh | Apr 3, 2026 traded Apr 1, 2026 |
| 10 | Rosett MaxChief Financial Officer |  IMNMImmunome Inc.Open-market sale · 10b5-1 plan | SELL | $30K 1,344 sh | Apr 3, 2026 traded Apr 2, 2026 |
| 10 | McGrane AshleyGeneral Counsel and Corp Sec |  GTMZoomInfo Technologies Inc.Open-market sale · 10b5-1 plan | SELL | $41K 6,959 sh | Apr 3, 2026 traded Apr 2, 2026 |
| 8 | Dutt SubirChief Sales Officer | XMTRXometry, Inc. Open-market sale · 10b5-1 plan | SELL | $21K 509 sh | Apr 3, 2026 traded Apr 2, 2026 |
| 8 | Sahni Sanjeev SinghPresident | XMTRXometry, Inc. Open-market sale · 10b5-1 plan | SELL | $5,030 124 sh | Apr 3, 2026 traded Apr 2, 2026 |
| 8 | Sahni Sanjeev SinghPresident | XMTRXometry, Inc. Open-market sale · 10b5-1 plan | SELL | $37K 891 sh | Apr 3, 2026 traded Apr 2, 2026 |
| 8 | Raghavan VaidyanathanChief Technology Officer | XMTRXometry, Inc. Open-market sale · 10b5-1 plan | SELL | $7,211 179 sh | Apr 3, 2026 traded Apr 2, 2026 |
| 8 | Dutt SubirChief Sales Officer | XMTRXometry, Inc. Open-market sale · 10b5-1 plan | SELL | $5,184 127 sh | Apr 3, 2026 traded Apr 2, 2026 |
| 8 | Dutt SubirChief Sales Officer | XMTRXometry, Inc. Open-market sale · 10b5-1 plan | SELL | $2,677 63 sh | Apr 3, 2026 traded Apr 2, 2026 |
| 8 | Sahni Sanjeev SinghPresident | XMTRXometry, Inc. Open-market sale · 10b5-1 plan | SELL | $4,078 96 sh | Apr 3, 2026 traded Apr 2, 2026 |
| 8 | Raghavan VaidyanathanChief Technology Officer | XMTRXometry, Inc. Open-market sale · 10b5-1 plan | SELL | $6,160 145 sh | Apr 3, 2026 traded Apr 2, 2026 |
| 7 | Kerdman AlinaSVP, Controller & CAO |  CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORPOpen-market sale · 10b5-1 plan | SELL | $12K 194 sh | Apr 3, 2026 traded Apr 2, 2026 |
| 5 | Steele Richard GSVP - General Counsel |  MCOMOODYS CORP /DE/Open-market sale · 10b5-1 plan | SELL | $15K 34 sh | Apr 3, 2026 traded Apr 1, 2026 |
| 1 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS |  NTRANatera, Inc.Open-market sale · 10b5-1 plan | SELL | $202K 1,000 sh | Apr 3, 2026 traded Apr 1, 2026 |
| 1 | Ruddy Marcella K.Chief Medical Officer |  TECXTectonic Therapeutic, Inc.Open-market sale · 10b5-1 plan | SELL | $31K 1,000 sh | Apr 3, 2026 traded Apr 1, 2026 |
| 1 | Majalya Sidney A.SVP, CLO and Secretary |  TNETTRINET GROUP, INC.Open-market sale · 10b5-1 plan | SELL | $29K 775 sh | Apr 3, 2026 traded Apr 1, 2026 |
| 1 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $211K 1,048 sh | Apr 3, 2026 traded Apr 1, 2026 |
| 1 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | NTRANatera, Inc. Open-market sale · 10b5-1 plan | SELL | $194K 952 sh | Apr 3, 2026 traded Apr 1, 2026 |
| 51 |  Kelly MorrisonDSelf | Andersen Corporation Partial sale | SELL | $250K – $500K | Apr 2, 2026 traded Jun 15, 2025 |
| 51 | Kelly MorrisonDSelf | Andersen Corporation Partial sale | SELL | $500K – $1.00M | Apr 2, 2026 traded Jan 20, 2025 |
| 51 | Kelly MorrisonDSelf | Andersen Corporation Partial sale | SELL | $250K – $500K | Apr 2, 2026 traded Mar 15, 2025 |
| 51 | Kelly MorrisonDSelf | Andersen Corporation Partial sale | SELL | $250K – $500K | Apr 2, 2026 traded Jan 20, 2026 |
| 45 | Kelly MorrisonDSelf | Andersen Corporation Partial sale | SELL | $100K – $250K | Apr 2, 2026 traded Sep 15, 2025 |
| 45 | Kelly MorrisonDSelf | Andersen Corporation Partial sale | SELL | $50K – $100K | Apr 2, 2026 traded Oct 15, 2025 |
| 30 | Kelly MorrisonDSelf | Andersen Corporation Partial sale | SELL | $100K – $250K | Apr 2, 2026 traded Mar 15, 2026 |
| 26 | Bernstein HaroldPresident, R&D & CMO |  MAZEMaze Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $332K 11.4K sh | Apr 2, 2026 traded Apr 1, 2026 |
| 26 | Mindlin Damian MiguelVice President |  PAMPampa Energy Inc.Open-market sale | SELL | $1.78M 500.0K sh | Apr 2, 2026 traded Mar 31, 2026 |
| 26 |  David J. TaylorRSelf |  KRKROGER COSale | SELL | $1,001 – $15K | Apr 2, 2026 traded Mar 24, 2026 |
| 24 | Perros EvangelosChief Financial Officer |  PGYPagaya Technologies Ltd.Open-market sale | SELL | $147K 13.0K sh | Apr 2, 2026 traded Apr 1, 2026 |
| 23 | Bernstein HaroldPresident, R&D & CMO | MAZEMaze Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $101K 3,348 sh | Apr 2, 2026 traded Apr 1, 2026 |
| 22 | Raghunathan VivekSVP, Engineering |  SNOWSnowflake Inc.Open-market sale · 10b5-1 plan | SELL | $592K 3,876 sh | Apr 2, 2026 traded Apr 1, 2026 |
| 22 | Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder |  HNGEHinge Health, Inc.Open-market sale · 10b5-1 plan | SELL | $1.90M 49.3K sh | Apr 2, 2026 traded Apr 1, 2026 |
| 21 | Lozinski Jeffrey William10% Owner |  KSEZKinetic Seas Inc.Open-market sale | SELL | $2,160 61.7K sh | Apr 2, 2026 traded Apr 1, 2026 |
| 21 | Lozinski Jeffrey William10% Owner | KSEZKinetic Seas Inc. Open-market sale | SELL | $1,500 50.0K sh | Apr 2, 2026 traded Apr 1, 2026 |
| 20 | Bernstein HaroldPresident, R&D & CMO | MAZEMaze Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $9,320 300 sh | Apr 2, 2026 traded Apr 1, 2026 |
| 17 | Beneski Benjamin MachinasSVP, Chief Technical Officer |  ALLOAllogene Therapeutics, Inc.Open-market sale | SELL | $7,168 2,867 sh | Apr 2, 2026 traded Mar 31, 2026 |
| 15 | Bachrodt AmySVP, Finance | MAZEMaze Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $65K 2,200 sh | Apr 2, 2026 traded Apr 1, 2026 |
| 13 | Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder | HNGEHinge Health, Inc. Open-market sale · 10b5-1 plan | SELL | $26K 668 sh | Apr 2, 2026 traded Apr 1, 2026 |